Browsing Tag
BioCryst Pharmaceuticals
3 posts
How Astria Therapeutics’ sale signals a valuation reset for late-stage hereditary angioedema drug assets
Astria Therapeutics’ sale highlights a valuation reset for late-stage rare disease drug assets. Read how this deal reshapes biotech M&A strategy.
Island Pharmaceuticals stock climbs as FDA clears path for Galidesivir fast-track review
Island Pharmaceuticals (ASX: ILA) stock rises as FDA fast-tracks Galidesivir under the Animal Rule, with survival data, PRV potential, and stockpile contracts in focus.
Skechers, BioCryst, FTAI Aviation lead U.S. stock gainers as investors shift focus to sector-specific catalysts
See which U.S. stocks surged on May 5, 2025, and why gold, biotech, and aviation names like Skechers, BioCryst, and FTAI Aviation outperformed the market.